The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis

Marta Vaz Batista, José Manuel Pérez-García, Laia Garrigós, José Á. García-Sáenz, Patricia Cortez, Fabricio Racca, Salvador Blanch, Manuel Ruíz‐Borrego, Adela Fernández-Ortega, María Fernández, Vega Iranzo, María Gión, Griselda Martrat, Daniel Alcalá-López, Jhudit Pérez‐Escuredo, Miguel Sampayo-Cordero, Antonio Llombart‐Cussac, Sofía Braga, Javier Cortés